Sandbox: sadaf: Difference between revisions
Jump to navigation
Jump to search
Line 72: | Line 72: | ||
!Myelodysplastic syndromes | !Myelodysplastic syndromes | ||
! | ! | ||
| | | + | ||
| | | | ||
| | | | ||
Line 102: | Line 102: | ||
!Aplastic anemia | !Aplastic anemia | ||
! | ! | ||
| | | + | ||
| | | | ||
| | | | ||
Line 132: | Line 132: | ||
!Acute leukemia | !Acute leukemia | ||
! | ! | ||
| | | + | ||
| | | | ||
| | | | ||
Line 162: | Line 162: | ||
!Paroxysmal nocturnal hemoglobinuria (PNH) | !Paroxysmal nocturnal hemoglobinuria (PNH) | ||
! | ! | ||
| | | + | ||
| | | | ||
| | | | ||
Line 194: | Line 194: | ||
! | ! | ||
! | ! | ||
! | !+ | ||
! | ! | ||
! | ! | ||
Line 224: | Line 224: | ||
! | ! | ||
! | ! | ||
! | !+ | ||
! | ! | ||
! | ! | ||
Line 465: | Line 465: | ||
!Folate, vitamin B12, copper | !Folate, vitamin B12, copper | ||
|an autoimmune mechanism | |an autoimmune mechanism | ||
! | !+ | ||
! | ! | ||
! | ! | ||
Line 716: | Line 716: | ||
* An ITP-like condition called primary HIV-associated thrombocytopenia (PHAT) | * An ITP-like condition called primary HIV-associated thrombocytopenia (PHAT) | ||
* Secondary opportunistic infections | * Secondary opportunistic infections | ||
! | !+ | ||
! | ! | ||
! | ! | ||
Line 911: | Line 911: | ||
! | ! | ||
| | | | ||
| | | + | ||
| | | | ||
| | | | ||
Line 942: | Line 942: | ||
! | ! | ||
|Predictable, dose-dependent myelosuppression | |Predictable, dose-dependent myelosuppression | ||
| | | + | ||
| | | | ||
| | | | ||
Line 1,005: | Line 1,005: | ||
! | ! | ||
| | | | ||
| | | + | ||
| | | | ||
| | | |
Revision as of 21:03, 14 August 2018
Thrombocytopenia Differential Diagnosis
Differentiating the diseases that can cause thrombocytopenia:
Category | Condition | Mechanism | Age range | Clinical manifestations | Para−clinical findings | Gold standard | Associated findings | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Signs | |||||||||||||||||||||||||||||
Lab Findings | Imaging | |||||||||||||||||||||||||||||
Severity | Fever | Bleeding | BP | Splenomegaly | CBC | PBS | Bone marrow exam | |||||||||||||||||||||||
Myelosuppression | Platelet destruction in bloodstream | Platelet destruction in spleen/liver | History | Plt | HB | WBC | PT | PTT | BT | |||||||||||||||||||||
Hematology | Bone marrow disorders | Myelodysplastic syndromes | + | |||||||||||||||||||||||||||
Aplastic anemia | + | |||||||||||||||||||||||||||||
Acute leukemia | + | |||||||||||||||||||||||||||||
Paroxysmal nocturnal hemoglobinuria (PNH) | + | Diagnosis of exclusion | ||||||||||||||||||||||||||||
Thrombotic microangiopathy (TMA) | Thrombotic thrombocytopenic purpura (TTP) | + | ||||||||||||||||||||||||||||
Hemolytic uremic syndrome (HUS) | + | |||||||||||||||||||||||||||||
Congenital platelet disorders | MYH-9 related disorders | |||||||||||||||||||||||||||||
Bernard-Soulier syndrome | ||||||||||||||||||||||||||||||
Gray platelet syndrome | ||||||||||||||||||||||||||||||
Wiskott-Aldrich syndrome | ||||||||||||||||||||||||||||||
Thrombocytopenia with absent radius (TAR) syndrome | ||||||||||||||||||||||||||||||
Alport syndrome | ||||||||||||||||||||||||||||||
Von Willebrand disease | ||||||||||||||||||||||||||||||
Nutrient deficiencies | Folate, vitamin B12, copper | an autoimmune mechanism | + | |||||||||||||||||||||||||||
Rheumatologic/autoimmune disorders | Immune thrombocytopenia | Antibody-mediated platelet destruction | Moderate to severe | - | ||||||||||||||||||||||||||
Systemic lupus erythematosus (SLE) | ||||||||||||||||||||||||||||||
Antiphospholipid syndrome (APS) | autoantibody-mediated syndrome | |||||||||||||||||||||||||||||
Felty's syndrome | splenomegaly | |||||||||||||||||||||||||||||
Infection-induced | Bacterial infections | Sepsis | Direct bone marrow suppression | + | ||||||||||||||||||||||||||
Helicobacter pylori | Immune thrombocytopenia | |||||||||||||||||||||||||||||
Tick-borne infection | ||||||||||||||||||||||||||||||
Viral infections | HIV |
|
+ | |||||||||||||||||||||||||||
Other viruses such as rubella, mumps, varicella, parvovirus, hepatitis C, & Epstein-Barr virus | ||||||||||||||||||||||||||||||
Intracellular parasites | Malaria | |||||||||||||||||||||||||||||
Babesiosis | ||||||||||||||||||||||||||||||
Medication/toxicity | Drug-induced immune thrombocytopenia |
|
Occurrence of drug-dependent, platelet-reactive antibodies | |||||||||||||||||||||||||||
Heparin-induced thrombocytopenia | ||||||||||||||||||||||||||||||
Cytotoxic chemotherapy | + | |||||||||||||||||||||||||||||
Radiation therapy | Predictable, dose-dependent myelosuppression | + | ||||||||||||||||||||||||||||
OTC agents | Quinine-containing beverages | |||||||||||||||||||||||||||||
GI | Chronic liver disease | + | Mild | |||||||||||||||||||||||||||
Portal hypertension | ||||||||||||||||||||||||||||||
Vascular | Giant capillary hemangioma | platelet destruction | ||||||||||||||||||||||||||||
Aortic aneurysm | platelet destruction | |||||||||||||||||||||||||||||
Cardiopulmonary bypass | platelet destruction | |||||||||||||||||||||||||||||
Other | Alcohol | |||||||||||||||||||||||||||||
Post-transfusion purpura | immune-mediated platelet destruction | |||||||||||||||||||||||||||||
Gestational thrombocytopenia |